Skip to main content
TipRanks
Go Ultimate75% OFF

OS Therapies Incorporated (OSTX) Stock Statistics & Valuation Metrics

270 Followers

Total Valuation

OS Therapies Incorporated has a market cap or net worth of $35.62M. The enterprise value is $84.28M.

Market Cap
$35.62M
Enterprise Value
$84.28M

Share Statistics

OS Therapies Incorporated has 52,322,483 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
52,322,483
Owned by Insiders
8.02%
Owned by Institutions
5.03%

Financial Efficiency

OS Therapies Incorporated’s return on equity (ROE) is 4.72 and return on invested capital (ROIC) is 582.87%.

Return on Equity (ROE)
4.72
Return on Assets (ROA)
-4.20
Return on Invested Capital (ROIC)
582.87%
Return on Capital Employed (ROCE)
5.83
Revenue Per Employee
0
Profits Per Employee
-5.75M
Employee Count
5
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of OS Therapies Incorporated is -0.63. OS Therapies Incorporated’s PEG ratio is 0.01.

PE Ratio
-0.63
PS Ratio
0.00
PB Ratio
-0.00
Price to FCF
-1.74
Price to Operating Cash Flow
-1.63
PEG Ratio
0.01

Income Statement

In the last 12 months, OS Therapies Incorporated had revenue of 0 and earned -28.75M in profits. Earnings per share was -0.98.

Revenue
0
Gross Profit
-363.08K
Operating Income
-28.71M
Pretax Income
-28.75M
Net Income
-28.75M
EBITDA
-28.39M
Earnings Per Share (EPS)
-0.98

Cash Flow

In the last 12 months, operating cash flow was -18.53M and capital expenditures 0, giving a free cash flow of -18.53M billion.

Operating Cash Flow
-18.53M
Free Cash Flow
-18.53M
Free Cash Flow per Share
-0.42

Dividends & Yields

OS Therapies Incorporated pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-58.06%
Earnings Yield
-131.48%

Stock Price Statistics

Beta
0.50
52-Week Price Change
-62.22%
50-Day Moving Average
1.43
200-Day Moving Average
1.54
Relative Strength Index (RSI)
14.88
Average Volume (3m)
687.99K

Important Dates

OS Therapies Incorporated upcoming earnings date is Apr 06, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 13, 2026
Next Earnings Date
Apr 06, 2027
Ex-Dividend Date
―

Financial Position

OS Therapies Incorporated as a current ratio of 0.03, with Debt / Equity ratio of 0.00%

Current Ratio
0.03
Quick Ratio
0.03
Debt to Market Cap
0.00
Net Debt to EBITDA
0.01
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, OS Therapies Incorporated has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

OS Therapies Incorporated EV to EBITDA ratio is 4.47, with an EV/FCF ratio of 9.34.

EV to Sales
0.00
EV to EBITDA
4.47
EV to Free Cash Flow
9.34
EV to Operating Cash Flow
9.34

Balance Sheet

OS Therapies Incorporated has $205.03M in cash and marketable securities with $0.00 in debt, giving a net cash position of $205.03M billion.

Cash & Marketable Securities
$205.03M
Total Debt
$0.00
Net Cash
$205.03M
Net Cash Per Share
$3.92
Tangible Book Value Per Share
-$389.48

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for OS Therapies Incorporated is $8.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$8.33
Price Target Upside
1125.49% Upside
Analyst Consensus
Strong Buy
Analyst Count
3
Revenue Growth Forecast
―
EPS Growth Forecast
-41.63%

Scores

Smart Score
4
AI Score
41